Skip to main content
What types of page to search?

Popular pages: Undergraduate Postgraduate PhD Accommodation Research International students

Alternatively use our A-Z index.

Funded projects

We carry out a wide range of research projects, often in collaboration with partners in academia and in industry. Explore the diverse portfolio of funded research projects we work on and see how we are delivering global change.

These projects are what CELT Global Health are currently working on. We also have an archive of projects that are either finished or our part in them is complete. You can find this archive on our previous projects page.

CELT Global Health celtic knot with the word Climate and Sustainability next to it and CELT Global Health written under that

Climate and sustainability

CELT Global Health are conducting a literature review to explore the viability of long-acting technologies, for use in low- and middle- income countries that are facing systemic instability and environmental disruption.

the LONGEVITY logo is the CELT Global Health celtic knot with the words Community of Practice next to it and CELT Global Health written under that

CELT Global Health's Community of Practice for long-acting therapeutics for maternal and paediatric health

The overarching aim of this Community of Practice is to catalyse the development and availability of long-acting therapeutics of value for maternal and paediatric health globally, including in low- and middle- income countries.

The Unitaid logo is a origami style hummingbird, the word Unitaid and then the tagline 'Save lives faster' underneath

Implementation research

This study, in partnership with Liverpool School of Tropical Medicine, aims to better understand community and health workforce perceptions of long-acting therapeutics for managing chronic infectious diseases in low- and middle- income countries.

The leap logo is the word leap with a chevron at the end

Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)

CELT Global Health investigators sit on the Executive Board of LEAP and run a modelling and simulation core to support development and implementation of long-acting medicines for HIV, viral hepatitis and tuberculosis treatment and prevention.

the LONGEVITY logo is the CELT Global Health celtic knot with the word LONGEVITY next to it and CELT Global Health written under that

LONGEVITY project

CELT Global Health researchers are working with colleagues across the globe to develop interventions for malaria chemoprophylaxis, tuberculosis prevention and treatment of hepatitis C virus. Co-funding to establish CELT Global Health was provided through this award.

the LONGEVITY logo is the CELT Global Health celtic knot with the words Manufacturing Capability next to it and CELT Global Health written under that

Manufacturing capability

With support from Unitaid funding, CELT Global Health is developing an open access resource to address a gap in information for developers of long-acting therapeutic products for low- and middle- income country markets.

This logo is the letters UKRI stacked with the words

Nafamostat as COVID-19 Prevention

There is an urgent need for potential COVID-19 treatment candidates to be screened based on their pharmacokinetics. CELT Global Health use pharmacokinetic evidence to screen for candidates of interest to be generated and shared to ensure only the most effective treatments are taken forward to clinical trial.

the LONGEVITY logo is the CELT Global Health celtic knot with the words Partnership Coordination next to it and CELT Global Health written under that

Partnership coordination

The Long-acting Partnerships Strategy prioritises partnerships to accelerate global targets to reduce morbidity and mortality from major diseases. Incorporating activities to support access to long-acting products in low- and middle- income countries, this project brings together core activities aimed to develop equitable uptake of long-acting therapeutics.

the LONGEVITY logo is the CELT Global Health celtic knot with the words TB DARQ next to it and CELT Global Health written under that

TB DARQ - Harnessing potent next-generation diarylquinolines for long-acting injectable formulations to prevent and treat tuberculosis

Supporting a collaboration with Johns Hopkins University to develop long-acting injectable (LAI) formulations of next-generation diarylquinolines (DARQs) with and without possible companion agents for TB preventive therapy (TPT) and for use during the continuation phase of active TB treatment.